[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kenyatta National Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":85},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,52],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100596843","accelerating-adoption-of-patient-centered-cervical-cancer-screening-and-treatment-linkage-in-kenya-100596843",false,"NCT07050745","Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya","DADA-LINK","Inclusion Criteria:\n\n\\- Women ages 25-49 years\n\nExclusion Criteria:\n\n* Pregnant women\n* Women ≤6 weeks postpartum\n* Women already confirmed to have cervical cancer",true,"FEMALE","25 Years","49 Years",{"count":21,"type":22},1980,"ESTIMATED","INTERVENTIONAL",[25],"NA","This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage\u002Ftreatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).",[28,29,30],"Cervical Cancer","Cervical Cancer Screening","HPV DNA",[32,33,34,35,36,37,38],"cervical cancer","screening","m-Health","linkage to treatment","VIA","HPV","HPV self-sampling","RECRUITING","2026-01-08",{"date":42,"type":43},"2026-01-12","ACTUAL",{"date":45,"type":43},"2025-12-01",{"date":47,"type":22},"2026-12",{"name":49,"class":50},"Kenyatta National Hospital","OTHER_GOV",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":16,"sex":17,"minAge":59,"maxAge":4,"enrollmentInfo":60,"targetDuration":4,"studyType":23,"phases":62,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":5},"100551147","integration-of-stepped-care-for-perinatal-mood-and-anxiety-disorders-among-women-attending-mch-clinics-100551147","NCT06456307","Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics","IPMH","Inclusion Criteria:\n\n* Pregnant and ≥28 weeks gestation\n* Attending ANC care at the facility\n* ≥14 years old\n* Screen positive for PMAD symptoms (PHQ-2≥3 and\u002For GAD-2≥3)\n* Willing to return to the MCH and PMTCT clinic for study visits\n\nExclusion Criteria:\n\n* Less than 28 weeks gestation\n* Any woman at high risk of self-harm based on a study self-harm assessment protocol,\n* Has cognitive impairments or psychotic symptoms","14 Years",{"count":61,"type":22},2970,[25],"Perinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interventions are recommended for identification and management of PMAD by non-specialist providers in resource-limited settings. This cluster-randomized trial seeks to evaluate the effect of a stepped-care intervention for screening and treatment of PMAD among perinatal women, on clinical and implementation outcomes.",[65,66,67],"Depression, Anxiety","Antenatal Depression","Postnatal Depression",[69,70,71,72,73,74,75,76],"perinatal mood and anxiety disorders","telepsychiatry","Problem management plus","Integrated Perinatal Mental Health","Pregnancy","Postpartum","Depression","Anxiety","2025-12-03",{"date":79,"type":43},"2025-12-10",{"date":81,"type":43},"2025-02-17",{"date":83,"type":22},"2028-03",{"name":49,"class":50},""]